University College of Northern Denmark
Aalborg, 9220, Denmark
Location status: Recruiting
Location contact
Morten P Støve, PT, Msc.
CONTACT
Morten P Støve, PT, Msc.
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06487741
This randomised controlled trial will examine the clinical efficacy of a six-week, novel, home-based stretching programme compared to usual care on the effect of symptoms experienced by patients with fibromyalgia.
Interested in participating?
Request Info18 year–60 year
All sexes
Interventional
Not applicable
Aalborg, 9220, Denmark
Location status: Recruiting
Morten P Støve, PT, Msc.
CONTACT
Morten P Støve, PT, Msc.
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention comprises six weeks of daily static stretching exercises (six minutes a day) in accordance with the recommendation of the American College of Sports Medicine. The intervention is self-administered and consists of two bouts of 30-second bilateral static stretches of the knee flexors, hip abductors, and shoulder elevators.
Time frame: Measured at baseline
The Revised Fibromyalgia Impact Questionnaire (FIQ-R) total score
Time frame: Measured following 6 weeks of intervention (primary endpoint)
The Revised Fibromyalgia Impact Questionnaire (FIQ-R) total score
Time frame: Measured 6 months after the primary endpoint (secondary endpoint)
The Revised Fibromyalgia Impact Questionnaire (FIQ-R) total score
Time frame: Measured at baseline
HRQL is assessed using the Danish version of the Short Form-36
Time frame: Measured following 6 weeks of intervention (primary endpoint)
HRQL is assessed using the Danish version of the Short Form-36
Time frame: Measured 6 months after the primary endpoint (secondary endpoint)
HRQL is assessed using the Danish version of the Short Form-36
Time frame: Measured at baseline
The International Physical Activity Questionnaire (IPAQ) short form
Time frame: Measured following 6 weeks of intervention (primary endpoint)
The International Physical Activity Questionnaire (IPAQ) short form
Time frame: Measured 6 months after the primary endpoint (secondary endpoint)
The International Physical Activity Questionnaire (IPAQ) short form
Time frame: Measured at baseline
Passive knee extension range of motion is assessed using the Biodex System 4 Pro isokinetic dynamometer
Time frame: Measured following 6 weeks of intervention (primary endpoint)
Passive knee extension range of motion is assessed using the Biodex System 4 Pro isokinetic dynamometer
Time frame: Measured at baseline
Pain sensitivity expressed as pressure pain thresholds are assessed using a handheld electronic pressure algometer
Time frame: Measured following 6 weeks of intervention (primary endpoint)
Pain sensitivity expressed as pressure pain thresholds are assessed using a handheld electronic pressure algometer
Time frame: Measured following 6 weeks of intervention (primary endpoint)
Adherence to the intervention is evaluated by the number of days stretching is performed using the self-reported data from the mHealth app.
Contact information is provided by the study sponsor or research team.
Allan Riis, PT. Ph.D.
CONTACT
Morten P Støve, PT. Msc.
CONTACT
University College of Northern Denmark
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05331430
Dry Needling, Fibromyalgia
Murcia, Spain
View Trial DetailsNCT02876965
Fibromyalgia, Muscular Diseases
Moncada, Valencia, Spain
View Trial DetailsNCT04833465
Arthritis, Arthritis, Juvenile
Washington D.C., District of Columbia, United States
View Trial DetailsNCT07398417
Fibromyalgia, Hyperalgesia
Glendale, Arizona, United States
View Trial Details